BIOMAT Database Logo BIOMAT Database Logo

The efficacy of epicillin in enteric fever (a comparative study with that of chloramphenicol). 1977

K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin

Related Publications

K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
A comparative study of epicillin and chloramphenicol in the treatment of enteric fever.
January 1977, The Journal of international medical research,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Comparative study of the efficacy of chloramphenicol and a combination of chloramphenicol, broxyquinoline and brobanzoxaldine in the treatment of enteric fever.
July 1975, Indian pediatrics,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Enteric fever treated with chloramphenicol.
April 1954, Journal of the Indian Medical Association,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
A study of cases of enteric fever treated with chloramphenicol.
April 1953, Journal of the Indian Medical Association,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
In vitro sensitivity of enteric bacteria to epicillin, chloramphenicol, ampicillin and furazolidone.
January 1976, Current medical research and opinion,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Chloramphenicol-resistant enteric fever.
March 1992, The Journal of the Association of Physicians of India,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Chloramphenicol resistant enteric fever.
April 1993, Indian pediatrics,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Chloramphenicol-resistant enteric fever.
April 1982, The Journal of the Association of Physicians of India,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Chloramphenicol resistant enteric fever.
January 1993, Journal of the Indian Medical Association,
K V Thiruvengadam, and K Haranath, and T V Devarajan, and S Nalin
Chloramphenicol in the treatment of enteric fever.
January 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!